Terms: = Endocrine gland cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Prognosis
13 results:
1. Characterization of the genomic alterations in poorly differentiated thyroid cancer.
Lee Y; Moon S; Seok JY; Lee JH; Nam S; Chung YS
Sci Rep; 2023 Nov; 13(1):19154. PubMed ID: 37932340
[TBL] [Abstract] [Full Text] [Related]
2. RREB1 promotes the development of parafollicular carcinogenesis through the Ras-raf-1-ELK3 signaling pathway.
Ma S; Wang H; Li W; Yan Z; Luo X; Lu P
Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):972-981. PubMed ID: 35737446
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
[TBL] [Abstract] [Full Text] [Related]
4. Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate raf1 expression.
Chen X; Wang J; Xie F; Mou T; Zhong P; Hua H; Liu P; Yang Q
Aging (Albany NY); 2020 Jul; 12(14):14452-14466. PubMed ID: 32678071
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Profiling of Follicular Variant of Papillary Thyroid cancer.
Spirina LV; Chizhevskaya SY; Kondakova IV
Bull Exp Biol Med; 2020 May; 169(1):85-88. PubMed ID: 32495172
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/raf1 axis.
Li G; Kong Q
Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440
[TBL] [Abstract] [Full Text] [Related]
7. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer.
Zhang Q; Yu S; Lok SIS; Wong AST; Jiao Y; Lee LTO
J Cell Mol Med; 2019 Jul; 23(7):4569-4581. PubMed ID: 31037837
[TBL] [Abstract] [Full Text] [Related]
8. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating raf1/MEK/ERK signaling.
Qi ZH; Xu HX; Zhang SR; Xu JZ; Li S; Gao HL; Jin W; Wang WQ; Wu CT; Ni QX; Yu XJ; Liu L
Int J Oncol; 2018 Apr; 52(4):1105-1116. PubMed ID: 29436617
[TBL] [Abstract] [Full Text] [Related]
9. In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.
Kodama M; Kodama T; Newberg JY; Katayama H; Kobayashi M; Hanash SM; Yoshihara K; Wei Z; Tien JC; Rangel R; Hashimoto K; Mabuchi S; Sawada K; Kimura T; Copeland NG; Jenkins NA
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7301-E7310. PubMed ID: 28811376
[TBL] [Abstract] [Full Text] [Related]
10. Screening for Thyroid cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lin JS; Bowles EJA; Williams SB; Morrison CC
JAMA; 2017 May; 317(18):1888-1903. PubMed ID: 28492904
[TBL] [Abstract] [Full Text] [Related]
11. Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid cancer.
Wei WJ; Sun ZK; Shen CT; Song HJ; Zhang XY; Qiu ZL; Luo QY
Theranostics; 2017; 7(4):987-1001. PubMed ID: 28382170
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.
Glover AR; Zhao JT; Gill AJ; Weiss J; Mugridge N; Kim E; Feeney AL; Ip JC; Reid G; Clarke S; Soon PS; Robinson BG; Brahmbhatt H; MacDiarmid JA; Sidhu SB
Oncotarget; 2015 Nov; 6(34):36675-88. PubMed ID: 26452132
[TBL] [Abstract] [Full Text] [Related]
13. Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells.
Jallal B; Schlessinger J; Ullrich A
J Biol Chem; 1992 Mar; 267(7):4357-63. PubMed ID: 1347042
[TBL] [Abstract] [Full Text] [Related]
